Clincosm LogoSign in Get a demo

cin3

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervix Uteri SIL, HPV, CIN2 Trial in Prague (Colposcopy)

Recruiting
  • Cervix Uteri SIL
  • +3 more
  • Colposcopy
  • Prague, Czechia
    General University Hospital
Nov 24, 2023

CIN3, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3 Trial in Groningen (Vvax001 therapeutic

Recruiting
  • CIN3
  • +3 more
  • Vvax001 therapeutic cancer vaccine
  • Groningen, Netherlands
    University Medical Center Groningen (UMCG)
Aug 23, 2023

Cervical Cancer, CIN2, CIN3 Trial in Westdene (5 Fluorouracil (5 FU) Cream, Placebo)

Not yet recruiting
  • Cervical Cancer
  • +4 more
  • 5 Fluorouracil (5 FU) Cream
  • Placebo
  • Westdene, Johannesburg, South Africa
    Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospita
Nov 30, 2022

Cervical Cancer, Genital Wart, CIN1 Trial (Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine

Not yet recruiting
  • Cervical Cancer
  • +11 more
  • Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha)
  • Placebo
  • (no location specified)
Oct 17, 2022

Cervical Cancer, CIN2, CIN3 Trial in Westdene (Urine HPV testing, Self-collected cervicovaginal specimen, Provider-collected

Not yet recruiting
  • Cervical Cancer
  • +2 more
  • Urine HPV testing
  • +2 more
  • Westdene, Johannesburg, South Africa
    Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospita
Sep 14, 2022

HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Guangxi (Experimental: Experimental: 9-valent Human Papillomavirus

Completed
  • HPV Infections
  • +14 more
  • Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
  • Active Comparator: GARDASIL ®9
  • Guangxi, China
    Guangxi Zhuang Autonomous Region Center for Disease Control and
May 9, 2022

After Whole Vaccination Shcedule With Recombination Quadrivalent

Not yet recruiting
  • HPV Infections
  • +6 more
    • (no location specified)
    May 7, 2022

    Cervical Cancer Screening With Human Papillomavirus Testing

    Recruiting
    • CIN3
    • +2 more
    • HPV screening
    • Buenos Aires, Argentina
    • +11 more
    Apr 1, 2022

    HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer Trial in Mianyang (2-doses Group among 9-14 years, 3-doses Group among

    Recruiting
    • HPV Infections
    • +6 more
    • 2-doses Group among 9-14 years
    • +2 more
    • Mianyang, Sichuan, China
      Center for Disease Control and Prevention
    Feb 23, 2022

    Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Yangchun (4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL®)

    Completed
    • Cervical Cancer
    • +13 more
    • 4-valent HPV Vaccine
    • +2 more
    • Yangchun, Guangdong, China
      Yangchun Center For Disease Prevention And Control
    Feb 23, 2022

    Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Rongan County (9-valent Human Papillomavirus (Types 6, 11, 16,

    Recruiting
    • Cervical Cancer
    • +13 more
    • 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha)
    • GARDASIL®
    • Rongan County, Guangxi Zhuang Autonomous Region, China
      Rongan County Center for Disease Control and Prevention
    Feb 20, 2022